or Try an Advanced Search...

    Technical Analysis for ARQT - Arcutis Biotherapeutics, Inc.

    Grade Last Price % Change Price Change
    B 12.25 -2.85% -0.36
    ARQT closed up 2.77 percent on Wednesday, December 4, 2024, on approximately normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical ARQT trend table...
    Date Alert Name Type % Chg
    1,2,3 Pullback Bullish Bullish Swing Setup -2.85%
    180 Bullish Setup Bullish Swing Setup -2.85%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.85%
    Outside Day Range Expansion -2.85%
    Wide Bands Range Expansion -2.85%
    Gapped Up Strength -2.85%
    Overbought Stochastic Strength -2.85%
    Upper Bollinger Band Walk Strength -0.16%
    Wide Bands Range Expansion -0.16%
    Overbought Stochastic Strength -0.16%
    Older End-of-Day Signals for ARQT ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 3 hours ago
    Down 2 % about 4 hours ago
    Down 1% about 5 hours ago
    60 Minute Opening Range Breakdown about 5 hours ago
    Bullish 180 Entry about 6 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ARQT Chart by TradingView
    Basic chart:

    Profile

    Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne on June 1, 2016 and is headquartered in Westlake Village, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Immunology Organ Systems Autoimmune Disease Psoriasis Atopic Dermatitis Dermatitis Type I Hypersensitivity Atopy Eczema Alopecia Areata Dermatological Diseases Plaque Psoriasis Vitiligo

    Is ARQT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Dec 3 Arcutis Announces Promotions on Executive Management Team
    Nov 27 Does Arcutis Biotherapeutics (ARQT) Have the Potential to Rally 60.12% as Wall Street Analysts Expect?
    Nov 27 Arcutis Biotherapeutics, Inc. (ARQT) Now Trades Above Golden Cross: Time to Buy?
    Nov 20 Arcutis Biotherapeutics, Inc. (ARQT) Recently Broke Out Above the 200-Day Moving Average
    Nov 20 Arcutis Biotherapeutics, Inc. (ARQT) Crossed Above the 50-Day Moving Average: What That Means for Investors
    Nov 19 Bears are Losing Control Over Arcutis Biotherapeutics (ARQT), Here's Why It's a 'Buy' Now
    Nov 19 Arcutis Biotherapeutics, Inc. (ARQT) Recently Broke Out Above the 20-Day Moving Average
    Nov 18 Arcutis Biotherapeutics: What Lies Ahead
    Nov 15 Arcutis Biotherapeutics: +200% On ZORYVE Approval, But When Is The Next Leg Up?
    Nov 13 Arcutis’ ZORYVE® (roflumilast) Awarded Best Eczema Treatment by Glamour
    See more ARQT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 13.5
    52 Week Low 1.89
    Average Volume 2,000,386
    200-Day Moving Average 9.66
    50-Day Moving Average 9.83
    20-Day Moving Average 10.80
    10-Day Moving Average 11.49
    Average True Range 0.72
    RSI (14) 68.65
    ADX 31.56
    +DI 39.75
    -DI 11.00
    Chandelier Exit (Long, 3 ATRs) 11.33
    Chandelier Exit (Short, 3 ATRs) 10.46
    Upper Bollinger Bands 12.94
    Lower Bollinger Band 8.66
    Percent B (%b) 0.92
    BandWidth 39.64
    MACD Line 0.78
    MACD Signal Line 0.54
    MACD Histogram 0.2476
    Fundamentals Value
    Market Cap 1.22 Billion
    Num Shares 96.8 Million
    EPS -4.33
    Price-to-Earnings (P/E) Ratio -2.91
    Price-to-Sales 13.14
    Price-to-Book 13.63
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 13.53
    Resistance 3 (R3) 13.46 13.08 13.37
    Resistance 2 (R2) 13.08 12.85 13.12 13.32
    Resistance 1 (R1) 12.85 12.71 12.97 12.92 13.27
    Pivot Point 12.47 12.47 12.53 12.51 12.47
    Support 1 (S1) 12.24 12.24 12.36 12.31 11.95
    Support 2 (S2) 11.86 12.10 11.90 11.90
    Support 3 (S3) 11.63 11.86 11.85
    Support 4 (S4) 11.70